About
Everyone in brain health waits for memory to fail. MoCA tests, blood, imaging, voice analysis: all of them measure the output, after the damage is done.
The brain depends on sensory inputs. Measure the inputs and you see decline years before memory moves. Cognition is downstream of sensory inputs. Measure the neuro inputs and you get the first real prevention window brain health has ever had. Published research backs it: a third lower dementia risk with early sensory intervention, while cognitive scores stayed flat the whole time (Cribb et al., Neurology 2026).
A UCLA surgeon lost his taste. Every doctor scanned his brain. No one tested his smell. We were the first to show him what had changed.
Senior living communities run it as annual programming, classes in a yearly wrapper, case studies available. Longevity and functional medicine clinics run it as the outcome measure they have never had: proof their protocols are reaching the brain. Clinicians finally get to see their work land. They treat the systems upstream of the brain and have never had a way to prove the brain responded. The inputs are that proof.
Built with Ph.D. researchers at Columbia, Johns Hopkins, Harvard, and NIH. 2,000+ assessments delivered. A category no one else owns.
We are here for pilot partners in senior living and clinical, and investors who want in early.
Founders Bio
Datar Sahi is the founder and CEO of SuperSenses. He holds a degree in Psychology with a minor in Business from the University of Oregon and previously co-founded 1 Degree. He is also a songwriter and musician. He started SuperSenses to build the brain health tool that did not exist when his own family needed it.
Origin Story
Datar's mother said her smell and taste were fading for fifteen years. She had glaucoma and only treated one eye. Everyone called it normal aging. Then she forgot his birthday, Halloween, the day he was born with his twin sister. Every signal had been there for over a decade. Not one of them was ever measured. That is why SuperSenses exists.
Product Overview
Honors and Awards
- Multiple US patents filed (2023/2024), with PCT international filing in progress.
- Research built with 15+ Ph.D. scientists across Columbia, Johns Hopkins, Harvard, and NIH, with IRB-validated trials underway and results expected Q4 2026.
- Invited contributor to a forthcoming Routledge handbook on brain health, co-authored with NIH and Columbia Ph.D.s.
- Featured in AGEIST and UCLA MedTech.
- Selected for the AgeTech Collaborative from AARP, Spring 2026 Accelerator cohort.